A more comprehensive understanding of CYP2D6 variation will help us better understand and ultimately predict interindividual PQ response, especially in the Malagasy and other admixed populations, where vivax malaria is a complex clinical and public health problem. This evidence concerns the gene CYP2D6 and Plasmodium vivax malaria.